ARS Pharmaceuticals Inc (SPRY)
11.34
+0.26
(+2.35%)
USD |
NASDAQ |
Jan 07, 16:00
11.34
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Shareholders Equity (Quarterly): 200.98M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis Inc | 2.275B |
| Assembly Biosciences Inc | 26.00M |
| Protagonist Therapeutics Inc | 531.92M |
| Precision BioSciences Inc | 64.87M |
| Avidity Biosciences Inc | 1.503B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.60M |
| Total Liabilities (Quarterly) | 16.62M |
| Current Ratio | 12.56 |